🇦🇺 Australia Country × Condition
endometrial cancer Clinical Trials in Australia
Active clinical trials for endometrial cancer with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, EARLY_Phase 1 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT05867251 Phase 1, Phase 2
Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
Enrollment
430 pts
Country
🇦🇺 Australia
Avenzo Therapeutics, Inc.
View Trial → NCT05123482 Phase 1, Phase 2
Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Enrollment
460 pts
Country
🇦🇺 Australia
AstraZeneca
View Trial → NCT06305962 EARLY_Phase 1
Recruiting
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Enrollment
30 pts
Country
🇦🇺 Australia
Radiopharm Theranostics, Ltd
View Trial → NCT07341737 Phase 1, Phase 2
Recruiting
SL-28 for Advanced Solid Tumours
Enrollment
60 pts
Country
🇦🇺 Australia
Second Life Therapeutics
View Trial → Frequently Asked Questions
How many endometrial cancer clinical trials are active in Australia?
There are currently 4 active clinical trials for endometrial cancer with sites in Australia, of which 4 are actively recruiting patients.
How can I join a endometrial cancer clinical trial in Australia?
To join a endometrial cancer clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are endometrial cancer trials in Australia?
Active endometrial cancer trials in Australia span Phase 1, Phase 2, EARLY_Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology